Sudden infant death syndrome accounts for 37% of sudden unexpected infant deaths a year in the U.S. On Saturday, researchers from The Children's Hospital Westmead in Sydney released a study that confirmed how these infants die and why.
#SIDS#BioSpace
The FDA plans to “rapidly make available” rare disease drugs and make use of surrogate endpoints to get promising medicines to patients before they clear the traditional efficacy bar for authorization, Prasad said Tuesday.
#fda#raredisease#biospace
